5-41853412-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000436.4(OXCT1):​c.414+7A>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0668 in 1,612,298 control chromosomes in the GnomAD database, including 6,945 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 2560 hom., cov: 32)
Exomes 𝑓: 0.060 ( 4385 hom. )

Consequence

OXCT1
NM_000436.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00006148
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.272

Publications

5 publications found
Variant links:
Genes affected
OXCT1 (HGNC:8527): (3-oxoacid CoA-transferase 1) This gene encodes a member of the 3-oxoacid CoA-transferase gene family. The encoded protein is a homodimeric mitochondrial matrix enzyme that plays a central role in extrahepatic ketone body catabolism by catalyzing the reversible transfer of coenzyme A from succinyl-CoA to acetoacetate. Mutations in this gene are associated with succinyl CoA:3-oxoacid CoA transferase deficiency. [provided by RefSeq, Jul 2008]
OXCT1 Gene-Disease associations (from GenCC):
  • succinyl-CoA:3-ketoacid CoA transferase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, Ambry Genetics, G2P, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 5-41853412-T-G is Benign according to our data. Variant chr5-41853412-T-G is described in ClinVar as [Benign]. Clinvar id is 93004.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OXCT1NM_000436.4 linkc.414+7A>C splice_region_variant, intron_variant Intron 4 of 16 ENST00000196371.10 NP_000427.1 P55809-1A0A024R040

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OXCT1ENST00000196371.10 linkc.414+7A>C splice_region_variant, intron_variant Intron 4 of 16 1 NM_000436.4 ENSP00000196371.5 P55809-1

Frequencies

GnomAD3 genomes
AF:
0.131
AC:
19937
AN:
152028
Hom.:
2557
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.336
Gnomad AMI
AF:
0.0362
Gnomad AMR
AF:
0.0718
Gnomad ASJ
AF:
0.0648
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0555
Gnomad FIN
AF:
0.0393
Gnomad MID
AF:
0.0764
Gnomad NFE
AF:
0.0548
Gnomad OTH
AF:
0.122
GnomAD2 exomes
AF:
0.0685
AC:
17200
AN:
251012
AF XY:
0.0650
show subpopulations
Gnomad AFR exome
AF:
0.343
Gnomad AMR exome
AF:
0.0421
Gnomad ASJ exome
AF:
0.0614
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0428
Gnomad NFE exome
AF:
0.0550
Gnomad OTH exome
AF:
0.0677
GnomAD4 exome
AF:
0.0601
AC:
87720
AN:
1460152
Hom.:
4385
Cov.:
31
AF XY:
0.0596
AC XY:
43324
AN XY:
726482
show subpopulations
African (AFR)
AF:
0.349
AC:
11668
AN:
33388
American (AMR)
AF:
0.0459
AC:
2051
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0620
AC:
1620
AN:
26112
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39676
South Asian (SAS)
AF:
0.0645
AC:
5556
AN:
86196
European-Finnish (FIN)
AF:
0.0400
AC:
2136
AN:
53334
Middle Eastern (MID)
AF:
0.0757
AC:
436
AN:
5762
European-Non Finnish (NFE)
AF:
0.0538
AC:
59726
AN:
1110660
Other (OTH)
AF:
0.0749
AC:
4520
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3640
7281
10921
14562
18202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2332
4664
6996
9328
11660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.131
AC:
19961
AN:
152146
Hom.:
2560
Cov.:
32
AF XY:
0.127
AC XY:
9463
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.336
AC:
13921
AN:
41460
American (AMR)
AF:
0.0717
AC:
1096
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0648
AC:
225
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5180
South Asian (SAS)
AF:
0.0547
AC:
264
AN:
4826
European-Finnish (FIN)
AF:
0.0393
AC:
417
AN:
10612
Middle Eastern (MID)
AF:
0.0719
AC:
21
AN:
292
European-Non Finnish (NFE)
AF:
0.0548
AC:
3727
AN:
67992
Other (OTH)
AF:
0.120
AC:
254
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
773
1547
2320
3094
3867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0823
Hom.:
1592
Bravo
AF:
0.145
Asia WGS
AF:
0.0560
AC:
196
AN:
3478
EpiCase
AF:
0.0604
EpiControl
AF:
0.0583

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 22, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Succinyl-CoA acetoacetate transferase deficiency Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 06, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.9
DANN
Benign
0.50
PhyloP100
0.27
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000061
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7723992; hg19: chr5-41853514; API